GP
VRTX icon

GLG Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

GLG Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,029
Closed -$433K – 518
2016
Q2 		$433K Buy
+5,029
New +$435K 0.02% 366
2015
Q4 		– Sell
-23,767
Closed -$2.48M – 539
2015
Q3 		$2.48M Buy
+23,767
New +$3.05M 0.08% 264
2015
Q2 		– Sell
-5,200
Closed -$613K – 532
2015
Q1 		$613K Sell
5,200
-53,785
-91% -$6.44M 0.02% 325
2014
Q4 		$7.01M Buy
58,985
+31,176
+112% +$3.51M 0.23% 131
2014
Q3 		$3.12M Buy
27,809
+12,809
+85% +$1.22M 0.08% 260
2014
Q2 		$1.42M Buy
+15,000
New +$1.05M 0.04% 287

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return